These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 33024402)
1. SMARCB1/INI1-deficient pancreatic undifferentiated rhabdoid carcinoma mimicking solid pseudopapillary neoplasm: A case report and review of the literature. Hua Y; Soni P; Larsen D; Zreik R; Leng B; Rampisela D World J Gastroenterol; 2020 Sep; 26(36):5520-5526. PubMed ID: 33024402 [TBL] [Abstract][Full Text] [Related]
2. Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor. Kohashi K; Izumi T; Oda Y; Yamamoto H; Tamiya S; Taguchi T; Iwamoto Y; Hasegawa T; Tsuneyoshi M Hum Pathol; 2009 Mar; 40(3):349-55. PubMed ID: 18973917 [TBL] [Abstract][Full Text] [Related]
3. SMARCB1/INI1 missense mutation in mucinous carcinoma with rhabdoid features. Cho YM; Choi J; Lee OJ; Lee HI; Han DJ; Ro JY Pathol Int; 2006 Nov; 56(11):702-6. PubMed ID: 17040295 [TBL] [Abstract][Full Text] [Related]
4. INI1-Deficient Thyroid Carcinoma is an Aggressive Disease with Epithelioid and Rhabdoid Phenotype. A Case Report, Survey of INI1 Expression in Thyroid Lesions and Literature Review. Liu Z; Seshadri M; Gupta V; Papanicolau-Sengos A; Merzianu M Head Neck Pathol; 2021 Dec; 15(4):1246-1252. PubMed ID: 34057693 [TBL] [Abstract][Full Text] [Related]
5. SMARCB1 (INI1)-negative rhabdoid carcinomas of the gastrointestinal tract: clinicopathologic and molecular study of a highly aggressive variant with literature review. Agaimy A; Rau TT; Hartmann A; Stoehr R Am J Surg Pathol; 2014 Jul; 38(7):910-20. PubMed ID: 24503755 [TBL] [Abstract][Full Text] [Related]
6. ERG and SALL4 expressions in SMARCB1/INI1-deficient tumors: a useful tool for distinguishing epithelioid sarcoma from malignant rhabdoid tumor. Kohashi K; Yamada Y; Hotokebuchi Y; Yamamoto H; Taguchi T; Iwamoto Y; Oda Y Hum Pathol; 2015 Feb; 46(2):225-30. PubMed ID: 25479928 [TBL] [Abstract][Full Text] [Related]
7. Pattern of SMARCB1 (INI1) and SMARCA4 (BRG1) in poorly differentiated endometrioid adenocarcinoma of the uterus: analysis of a series with emphasis on a novel SMARCA4-deficient dedifferentiated rhabdoid variant. Strehl JD; Wachter DL; Fiedler J; Heimerl E; Beckmann MW; Hartmann A; Agaimy A Ann Diagn Pathol; 2015 Aug; 19(4):198-202. PubMed ID: 25920939 [TBL] [Abstract][Full Text] [Related]
8. Pancreatic undifferentiated rhabdoid carcinoma: KRAS alterations and SMARCB1 expression status define two subtypes. Agaimy A; Haller F; Frohnauer J; Schaefer IM; Ströbel P; Hartmann A; Stoehr R; Klöppel G Mod Pathol; 2015 Feb; 28(2):248-60. PubMed ID: 25103069 [TBL] [Abstract][Full Text] [Related]
9. SMARCB1/INI1-deficient intrathoracic neoplasm with rhabdoid/plasmacytoid cytomorphology in a patient with plasma cell myeloma: A case report. Fujita K; Mizuguchi K; Mori T; Shimoda T; Sakano K; Shimaguchi C; Ito A; Yoshimura K; Sakaguchi M; Imi T; Ikeda H Diagn Cytopathol; 2023 Oct; 51(10):E294-E300. PubMed ID: 37475580 [TBL] [Abstract][Full Text] [Related]
10. The expanding family of SMARCB1(INI1)-deficient neoplasia: implications of phenotypic, biological, and molecular heterogeneity. Agaimy A Adv Anat Pathol; 2014 Nov; 21(6):394-410. PubMed ID: 25299309 [TBL] [Abstract][Full Text] [Related]
11. Non-rhabdoid pediatric SMARCB1-deficient tumors: overlap between chordomas and malignant rhabdoid tumors? Renard C; Pissaloux D; Decouvelaere AV; Bourdeaut F; Ranchère D Cancer Genet; 2014 Sep; 207(9):384-9. PubMed ID: 25053104 [TBL] [Abstract][Full Text] [Related]
13. SMARCB1/INI1-deficient sinonasal carcinoma shows methylation of RASSF1 gene: A clinicopathological, immunohistochemical and molecular genetic study of a recently described entity. Laco J; Chmelařová M; Vošmiková H; Sieglová K; Bubancová I; Dundr P; Němejcová K; Michálek J; Čelakovský P; Mottl R; Sirák I; Vošmik M; Ryška A Pathol Res Pract; 2017 Feb; 213(2):133-142. PubMed ID: 28069272 [TBL] [Abstract][Full Text] [Related]
14. SMARCB1/INI1-Deficient Poorly Differentiated Carcinoma of the Colon With Rhabdoid Features-A Rare Tumor With Serrated Phenotype: Case Report and Review of Literature. Maurya S; Yadav S; Bhowmik S; Dhal J; Mehra L; Sharma R; Krishna A; Sharma A; Barwad A; Das P Int J Surg Pathol; 2024 Feb; 32(1):187-195. PubMed ID: 37128676 [TBL] [Abstract][Full Text] [Related]
15. Loss of expression of SMARCA4 (BRG1), SMARCA2 (BRM) and SMARCB1 (INI1) in undifferentiated carcinoma of the endometrium is not uncommon and is not always associated with rhabdoid morphology. Ramalingam P; Croce S; McCluggage WG Histopathology; 2017 Feb; 70(3):359-366. PubMed ID: 27656868 [TBL] [Abstract][Full Text] [Related]
16. Oncogenic roles of SMARCB1/INI1 and its deficient tumors. Kohashi K; Oda Y Cancer Sci; 2017 Apr; 108(4):547-552. PubMed ID: 28109176 [TBL] [Abstract][Full Text] [Related]
17. SMARCB1/INI1-deficient undifferentiated carcinoma of the ileum with features of rhabdoid tumor: A case report. Duan T; Wang H; Jin Y Asian J Surg; 2024 Aug; 47(8):3559-3561. PubMed ID: 38908976 [No Abstract] [Full Text] [Related]
18. Head and neck INI1-deficient carcinoma without primary: a case report. Dubray-Vautrin A; Ghanem W; Bozec L; Gonin J; Choussy O J Med Case Rep; 2023 Nov; 17(1):479. PubMed ID: 37974295 [TBL] [Abstract][Full Text] [Related]
19. Re: Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor: Direct evidence of mutational inactivation of SMARCB1/INI1 in epithelioid sarcoma. Flucke U; Slootweg PJ; Mentzel T; Pauwels P; Hulsebos TJ Hum Pathol; 2009 Sep; 40(9):1361-2; author reply 1362-4. PubMed ID: 19683621 [No Abstract] [Full Text] [Related]
20. Mutation of the INI1 gene in composite rhabdoid tumor of the endometrium. Donner LR; Wainwright LM; Zhang F; Biegel JA Hum Pathol; 2007 Jun; 38(6):935-9. PubMed ID: 17376508 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]